Syncope. Therapeutic Approaches

Journal of the American College of Cardiology

Volumn 53, Issue 19, 2009, Pages 1741-1751

  Benditt, David G ^a   Nguyen, John T ^a  

^a Cardiac Arrhythmia Center   (United States)

Author keywords

cardiac arrhythmias; electrophysiology; hypotension; syncope

Indexed keywords

ATENOLOL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DISOPYRAMIDE; DIURETIC AGENT; FLUDROCORTISONE; METHYLPHENIDATE; METOPROLOL; MIDODRINE; PLACEBO; SCOPOLAMINE; SEROTONIN UPTAKE INHIBITOR; VASOCONSTRICTOR AGENT; VASODILATOR AGENT;

AGITATION; ARTERIAL PRESSURE; AUTOREGULATION; CLINICAL FEATURE; CLINICAL TRIAL; DIAGNOSTIC ACCURACY; DRUG EFFICACY; ELECTROCARDIOGRAM; FOLLOW UP; HEART ARRHYTHMIA; HISTORY OF MEDICINE; HUMAN; HYPERTENSION; HYPOKALEMIA; IRRITABILITY; MORTALITY; MOTOR DYSFUNCTION; NUTRIENT SUPPLY; PATHOPHYSIOLOGY; PRESCRIPTION; PRIORITY JOURNAL; QUALITY OF LIFE; REVIEW; RISK ASSESSMENT; SIDE EFFECT; SYNCOPE;

ADRENERGIC BETA-ANTAGONISTS; ANTI-INFLAMMATORY AGENTS; ARRHYTHMIAS, CARDIAC; CARDIAC PACING, ARTIFICIAL; ELECTROPHYSIOLOGY; FLUDROCORTISONE; HUMANS; RISK FACTORS; SYNCOPE; TILT-TABLE TEST; VASOCONSTRICTOR AGENTS;

EID: 65449170051     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacc.2008.12.065     Document Type: Review

References (76)

1. Brignole M., Alboni P., Benditt D.G., et al. Guidelines on management (diagnosis and treatment) of syncope-update 2004. Europace 6 (2004) 467-537
2. Bartoletti A., Fabiani P., Bagnoli L., et al. Physical injuries caused by a transient loss of consciousness: main clinical characteristics of patients and diagnostic contribution of carotid sinus massage. Eur Heart J 29 (2008) 618-624
3. Davies A.J., and Kenny R.A. Falls presenting to the accident and emergency department: types of presentation and risk factor profile. Age Ageing 25 (1996) 362-366
4. Benditt D.G., Olshansky B., Wieling W., and Ad Hoc Syncope Consortium. The ACCF/AHA scientific statement on syncope needs rethinking. J Am Coll Cardiol 48 (2006) 2598-2599
5. Bartoletti A., Fabiani P., Adriani P., et al. Hospital admission of patients referred to the emergency department for syncope: a single-hospital prospective study based on the application of the European Society of Cardiology Guidelines on Syncope. Eur Heart J 27 (2006) 83-88
6. Petkar S., Bell W., Rice N., Iddon P., Cooper P., and Fitzpatrick A. Rationale for a rapid access blackouts triage clinic. Brit J Cardiac Nursing 10 (2008) 468-474
7. Brignole M., Ungar A., Bartoletti A., et al. Standardized-care pathway vs. usual management of syncope patients presenting as emergencies at general hospitals. Europace 8 (2006) 644-650
8. Shen W.K., Decker W.W., Smars P.A., et al. Syncope Evaluation in the Emergency Department study (SEEDS): a multidisciplinary approach to syncope management. Circulation 110 (2004) 3636-3645
9. Costantino G., Perego F., Dipaola F., et al. Short- and long-term prognosis of syncope, risk factors, and role of hospital admission: results from the STePS (short-term prognosis of syncope) study. J Am Coll Cardiol 51 (2008) 276-283
10. Brignole M., and Shen W.K. Syncope management from emergency department to hospital. J Am Coll Cardiol 51 (2008) 284-287
11. Quinn J.V., Stiell I.G., McDermott D.A., Sellers K.L., Kohn M.A., and Wells G.A. Derivation of the San Francisco Syncope Rule to predict patients with short-term serious outcomes. Ann Emerg Med 43 (2004) 224-232
12. Colivicchi F., Ammirati F., Melina D., et al. Development and prospective validation of a risk stratification system for patients with syncope in the emergency department: the OESIL risk score. Eur Heart J 24 (2003) 811-819
13. Del Rosso A., Ungar A., Maggi R., et al. Clinical predictors of cardiac syncope at initial evaluation in patients referred urgently to general hospital: the EGSYS score. Heart 94 (2008) 1620-1626
14. Reed M.J., Newby D.E., Coull A.J., Jacques K.G., Prescott R.J., and Gray A.J. The Risk stratification Of Syncope in the Emergency department (ROSE) pilot study: a comparison of existing syncope guidelines. Emergency Med J 24 (2007) 270-275
15. Kapoor W.N. Diagnostic evaluation of syncope. Am J Med 90 (1991) 91-106
16. Calkins H., Shyr Y., Frumin H., Schork A., and Morady F. The value of the clinical history in the differentiation of syncope due to ventricular tachycardia, atrioventricular block, and neurocardiogenic syncope. Am J Med 98 (1995) 365-373
17. Alboni P., Brignole M., Menozzi C., et al. Diagnostic value of history in patients with syncope with or without heart disease. J Am Coll Cardiol 37 (2001) 1921-1928
18. Rothman S.A., Laughlin J.C., Seltzer J., et al. The diagnosis of cardiac arrhythmias: a prospective multi-center randomized study comparing mobile cardiac outpatient telemetry versus standard loop event monitoring. J Cardiovasc Electrophysiol 18 (2007) 241-247
19. Krahn A.D., Klein G.J., Yee R., and Skanes A.C. Randomized assessment of syncope trial: conventional diagnostic testing versus a prolonged monitoring strategy. Circulation 104 (2001) 46-51
20. Farwell D.J., Freemantle N., and Sulke A.N. Use of implantable loop recorders in the diagnosis and management of syncope. Eur Heart J 25 (2004) 1257-1263
21. Moya A., Brignole M., Menozzi C., et al. Mechanism of syncope in patients with isolated syncope and in patients with tilt-positive syncope. Circulation 104 (2001) 1261-1267
22. Brignole M., Sutton R., Menozzi C., et al. Early application of an implantable loop recorder allows effective specific therapy in patients with recurrent suspected neurally mediated syncope. Eur Heart J 27 (2006) 1085-1092
23. Soteriades E.S., Evans J.C., Larson M.G., et al. Incidence and prognosis of syncope. N Engl J Med 347 (2002) 878-885
24. Giada F., Silvestri I., Rossillo A., Nicotera P.G., Manzillo G.F., and Raviele A. Psychiatric profile, quality of life and risk of syncopal recurrence in patients with tilt-induced vasovagal syncope. Europace 7 (2005) 465-471
25. Leftheriotis D., Michopoulos I., Flevari P., et al. Minor psychiatric disorders and syncope: the role of psychopathology in the expression of vasovagal reflex. Psychother Psychosom 77 (2008) 372-376
26. Almquist A., Gornick C., Benson Jr. D.W., Dunnigan A., and Benditt D.G. Carotid sinus hypersensitivity: evaluation of the vasodepressor component. Circulation 71 (1985) 927-936
27. Kenny R.A., Richardson D.A., Steen N., Bexton R.S., Shaw F.E., and Bond J. Carotid sinus syndrome: a modifiable risk factor for nonaccidental falls in older adults (SAFE PACE). J Am Coll Cardiol 38 (2001) 1491-1496
28. Epstein A.E., Baessler C.A., Curtis A.B., et al. Addendum to public safety issues in patients with implantable defibrillators: a scientific statement from the American Heart Association and the Heart Rhythm Society. Circulation 115 (2007) 1170-1176
29. Krediet C.T., van Dijk N., Linzer M., van Lieshout J.J., and Wieling W. Management of vasovagal syncope: controlling or aborting faints by leg crossing and muscle tensing. Circulation 106 (2002) 1684-1689
30. Brignole M., Croci F., Menozzi C., et al. Isometric arm counter-pressure maneuvers to abort impending vasovagal syncope. J Am Coll Cardiol 40 (2002) 2053-2059
31. van Dijk N., Quartieri F., Blanc J.J., et al. Effectiveness of physical counterpressure maneuvers in preventing vasovagal syncope: the Physical Counterpressure Manoeuvres Trial (PC-Trial). J Am Coll Cardiol 48 (2006) 1652-1657
32. Ector H., Reybrouck T., Heidbuchel H., Gewillig M., and Van de Werf F. Tilt training: a new treatment for recurrent neurocardiogenic syncope and severe orthostatic intolerance. Pacing Clin Electrophysiol 21 (1998) 193-196
33. Di Girolamo E., Di Iorio C., Leonzio L., Sabatini P., and Barsotti A. Usefulness of a tilt training program for the prevention of refractory neurocardiogenic syncope in adolescents: a controlled study. Circulation 100 (1999) 1798-1801
34. Reybrouck T., Heidbuchel H., Van De Werf F., and Ector H. Long-term follow-up results of tilt training therapy in patients with recurrent neurocardiogenic syncope. Pacing Clin Electrophysiol 25 (2002) 1441-1446
35. Kinay O., Yazici M., Nazli C., et al. Tilt training for recurrent neurocardiogenic syncope: effectiveness, patient compliance, and scheduling the frequency of training sessions. Jpn Heart J 45 (2004) 833-843
36. Gurevitz O., Barsheshet A., Bar-Lev D., et al. Tilt training: Does it have a role in preventing vasovagal syncope?. Pacing Clin Electrophysiol 30 (2007) 1499-1505
37. El-Sayed H., and Hainsworth R. Salt supplement increases plasma volume and orthostatic tolerance in patients with unexplained syncope. Heart 75 (1996) 134-140
38. Parry S.W., and Kenny R.A. The management of vasovagal syncope. QJM 92 (1999) 697-705
39. Scott W.A., Pongiglione G., Bromberg B.I., et al. Randomized comparison of atenolol and fludrocortisone acetate in the treatment of pediatric neurally mediated syncope. Am J Cardiol 76 (1995) 400-402
40. Salim M.A., and Di Sessa T.G. Effectiveness of fludrocortisone and salt in preventing syncope recurrence in children: a double-blind, placebo-controlled, randomized trial. J Am Coll Cardiol 45 (2005) 484-488
41. Raj S.R., Rose S., Ritchie D., Sheldon R.S., and POST II Investigators. The Second Prevention of Syncope Trial (POST II)-a randomized clinical trial of fludrocortisone for the prevention of neurally mediated syncope: rationale and study design. Am Heart J 151 (2006) 1186.e1-1186.e7
42. Muller G., Deal B.J., Strasburger J.F., and Benson Jr. D.W. Usefulness of metoprolol for unexplained syncope and positive response to tilt testing in young persons. Am J Cardiol 71 (1993) 592-595
43. Cohen M.B., Snow J.S., Grasso V., et al. Efficacy of pindolol for treatment of vasovagal syncope. Am Heart J 130 (1995) 786-790
44. Iskos D., Dutton J., Scheinman M.M., and Lurie K.G. Usefulness of pindolol in neurocardiogenic syncope. Am J Cardiol 82 (1998) 1121-1124 A9.
45. Mahanonda N., Bhuripanyo K., Kangkagate C., et al. Randomized double-blind, placebo-controlled trial of oral atenolol in patients with unexplained syncope and positive upright tilt table test results. Am Heart J 130 (1995) 1250-1253
46. Sheldon R., Connolly S., Rose S., et al. Prevention of Syncope Trial (POST): a randomized, placebo-controlled study of metoprolol in the prevention of vasovagal syncope. Circulation 113 (2006) 1164-1170
47. Sutton R., Brignole M., Menozzi C., et al., Vasovagal Syncope International Study (VASIS) Investigators. Dual-chamber pacing in the treatment of neurally mediated tilt-positive cardioinhibitory syncope: pacemaker versus no therapy. Circulation 102 (2000) 294-299
48. Jankovic J., Gilden J.L., Hiner B.C., et al. Neurogenic orthostatic hypotension: a double-blind, placebo-controlled study with midodrine. Am J Med 95 (1993) 38-48
49. Ward C.R., Gray J.C., Gilroy J.J., and Kenny R.A. Midodrine: a role in the management of neurocardiogenic syncope. Heart 79 (1998) 45-49
50. Perez-Lugones A., Schweikert R., Pavia S., et al. Usefulness of midodrine in patients with severely symptomatic neurocardiogenic syncope: a randomized control study. J Cardiovasc Electrophysiol 12 (2001) 935-938
51. Grubb B.P., Kosinski D., Mouhaffel A., and Pothoulakis A. The use of methylphenidate in the treatment of refractory neurocardiogenic syncope. Pacing Clin Electrophysiol 19 (1996) 836-840
52. Grubb B.P., Wolfe D.A., Samoil D., Temesy-Armos P., Hahn H., and Elliott L. Usefulness of fluoxetine hydrochloride for prevention of resistant upright tilt induced syncope. Pacing Clin Electrophysiol 16 (1993) 458-464
53. Di Girolamo E., Di Iorio C., Leonzio L., Sabatini P., Ranalli G., and Barsotti A. Effectiveness of paroxetine in the treatment of refractory vasovagal syncope in young patients. G Ital Cardiol 29 (1999) 1472-1477
54. Takata T.S., Wasmund S.L., Smith M.L., et al. Serotonin reuptake inhibitor (paxil) does not prevent the vasovagal reaction associated with carotid sinus massage and/or lower body negative pressure in healthy volunteers. Circulation 106 (2002) 1500-1504
55. Brignole M., Menozzi C., Lolli G., Bottoni N., and Gaggioli G. Long-term outcome of paced and nonpaced patients with severe carotid sinus syndrome. Am J Cardiol 69 (1992) 1039-1043
56. Epstein A.E., DiMarco J.P., Ellenbogen K.A., et al. ACC/AHA/HRS 2008 guidelines for device-based therapy of cardiac rhythm abnormalities: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices) developed in collaboration with the American Association for Thoracic Surgery and Society of Thoracic Surgeons. J Am Coll Cardiol 51 (2008) e1-e62
57. Connolly S.J., Sheldon R., Roberts R.S., and Gent M. The North American Vasovagal Pacemaker Study (VPS). A randomized trial of permanent cardiac pacing for the prevention of vasovagal syncope. J Am Coll Cardiol 33 (1999) 16-20
58. Ammirati F., Colivicchi F., Santini M., and Syncope Diagnosis and Treatment Study Investigators. Permanent cardiac pacing versus medical treatment for the prevention of recurrent vasovagal syncope: a multicenter, randomized, controlled trial. Circulation 104 (2001) 52-57
59. Connolly S.J., Sheldon R., Thorpe K.E., et al. Pacemaker therapy for prevention of syncope in patients with recurrent severe vasovagal syncope: Second Vasovagal Pacemaker Study (VPS II): a randomized trial. JAMA 289 (2003) 2224-2229
60. Raviele A., Giada F., Menozzi C., et al. A randomized, double-blind, placebo-controlled study of permanent cardiac pacing for the treatment of recurrent tilt-induced vasovagal syncope. The Vasovagal Syncope and Pacing Trial (SYNPACE). Eur Heart J 25 (2004) 1741-1748
61. Brignole M. International Study on Syncope of Uncertain Aetiology 3 (ISSUE 3): pacemaker therapy for patients with asystolic neurally-mediated syncope: rationale and study design. Europace 9 (2007) 25-30
62. Mathias C.J., Deguchi K., and Schatz I. Observations on recurrent syncope and presyncope in 641 patients. Lancet 357 (2001) 348-353
63. Mathias C.J. Autonomic diseases: clinical features and laboratory evaluation. J Neurol Neurosurg Psychiatry 74 Suppl 3 (2003) iii31-iii41
64. Young T.M., and Mathias C.J. The effects of water ingestion on orthostatic hypotension in two groups of chronic autonomic failure: multiple system atrophy and pure autonomic failure. J Neurol Neurosurg Psychiatry 75 (2004) 1737-1741
65. Hoeldtke R.D., and Streeten D.H. Treatment of orthostatic hypotension with erythropoietin. N Engl J Med 329 (1993) 611-615
66. Kawakami K., Abe H., Harayama N., and Nakashima Y. Successful treatment of severe orthostatic hypotension with erythropoietin. Pacing Clin Electrophysiol 26 (2003) 105-107
67. Robertson D., Goldberg M.R., Hollister A.S., Wade D., and Robertson R.M. Clonidine raises blood pressure in severe idiopathic orthostatic hypotension. Am J Med 74 (1983) 193-200
68. Hoeldtke R.D., and Israel B.C. Treatment of orthostatic hypotension with octreotide. J Clin Endocrinol Metab 68 (1989) 1051-1059
69. Mathias C.J., Fosbraey P., da Costa D.F., Thornley A., and Bannister R. The effect of desmopressin on nocturnal polyuria, overnight weight loss, and morning postural hypotension in patients with autonomic failure. Br Med J (Clin Res Ed) 293 (1986) 353-354
70. Brignole M., Menozzi C., Moya A., et al. Mechanism of syncope in patients with bundle branch block and negative electrophysiological test. Circulation 104 (2001) 2045-2050
71. Menozzi C., Brignole M., Garcia-Civera R., et al. Mechanism of syncope in patients with heart disease and negative electrophysiologic test. Circulation 105 (2002) 2741-2745
72. Olshansky B., Poole J.E., Johnson G., et al. Syncope predicts the outcome of cardiomyopathy patients: analysis of the SCD-HeFT study. J Am Coll Cardiol 51 (2008) 1277-1282
73. Fananapazir L., Epstein N.D., Curiel R.V., Panza J.A., Tripodi D., and McAreavey D. Long-term results of dual-chamber (DDD) pacing in obstructive hypertrophic cardiomyopathy. Circulation 90 (1994) 2731-2742
74. Shechter A., Stewart W.F., Silberstein S.D., and Lipton R.B. Migraine and autonomic nervous system function: a population-based, case-control study. Neurology 58 (2002) 422-427
75. Silberstein S.D. Practice parameter: evidence-based guidelines for migraine headache: report of the quality standards subcommittee of the American Academy of Neurology. Neurology 55 (2000) 754-762
76. Hadjipetrou P., Cox S., Piemonte T., and Eisenhauer A. Percutaneous revascularization of atherosclerotic obstruction of aortic arch vessels. J Am Coll Cardiol 33 (1999) 1238-1245